Camfil USA, Inc.
USPTO PatentsView assignee record - 24 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01D (Separation).
The verdict
According to USPTO PatentsView, Camfil ranks #12,380 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 12 technology areas.
- #12,380
- of 49,997 US assignees by volume
- 37th percentile
- by Innovation Score (31.2/100)
- 13.1
- avg claims per patent
- -90%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R12380 · US Corporation #12,380 · 24 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 24 grants
- UPPER-Q #12,380/49,997
- PHOTO-FINISH Biotest
- CPC-FOCUS B01D · 12 areas
- INNOV-THIN 31.2/100
- CLAIMS-RICH 13.1 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -90% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Biotest AG (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Camfil’s 31.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Camfil
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Camfil USA · this assignee 31
Camfil USA · this assignee
31 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Camfil's Innovation Score is 31.2/100 (37th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Camfil?
Each dot is one of Camfil’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Camfil’s own 13.1 claims/patent is ABOVE the 12.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Camfil's grants concentrate
Camfil USA, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 79.2% of grants classified under B01D (Separation). Peak complete grant year is 2015 (10 grants) versus a trough of 1 in 2017. By volume, Camfil sits between Biotest AG and Constellium Neuf-brisach.
Who files at Camfil's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Biotest
Biotest AG
24 patents
- Bison Designs
Bison Designs, LLC
24 patents
- Burton
Burton Technologies, LLC
24 patents
- Calitor Sciences
Calitor Sciences, LLC
24 patents
- Centrillion Techn…
Centrillion Technology Holdings Corporation
24 patents
- China National Of…
China National Offshore OIL Corporation
24 patents
- Claas Saulgau
Claas Saulgau GmbH
24 patents
- Constellium Neuf-…
Constellium Neuf-brisach
24 patents
- Camfil USA ◀
Camfil USA, Inc.
24 patents
What this shows Camfil holds 24 patents at rank #12,380, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Camfil
By rank, the assignees closest to #12,380 in granted patent volume.
- Biotest AG #12,376 · 24 patents
- Bison Designs, LLC #12,377 · 24 patents
- Burton Technologies, LLC #12,378 · 24 patents
- Calitor Sciences, LLC #12,379 · 24 patents
- Centrillion Technology Holdings Corporation #12,381 · 24 patents
- China National Offshore OIL Corporation #12,382 · 24 patents
- Claas Saulgau GmbH #12,383 · 24 patents
- Constellium Neuf-brisach #12,384 · 24 patents
Leaders in B01D (Separation)
Other assignees with the most granted patents in Camfil's primary technology class.
Camfil's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 37th percentile higher than 37% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 10 | 41.7% |
| 2016 | 4 | 16.7% |
| 2017 | 1 | 4.2% |
| 2018 | 3 | 12.5% |
| 2019 | 3 | 12.5% |
| 2020 | 2 | 8.3% |
| 2025partial year | 1 | 4.2% |
Which technologies does Camfil USA, Inc. patent most?
Top 12 of 12 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Camfil USA, Inc.'s patent record in context - here's where to go next.
- Camfil USA, Inc.'s lead technology class is B01D (Separation), 79.2% of its portfolio - see every assignee active in that class. Explore B01D
- Ranked #12,380 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Camfil USA, Inc. against Biotest AG, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 31.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.